FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, namely otorhinolaryngology, and can be used for treating otitis media by introducing a fluid composition of moxifloxacin with a viscosity of 100,000 cPs at temperature 25°C into an ear.
EFFECT: method allows to increase the clinical effectiveness in otitis media due to localising the composition on the tympanic membrane.
27 cl, 22 dwg, 10 tbl, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MODULATION OF HEPARIN-BINDING EPIDERMAL GROWTH FACTOR ACTIVITY FOR TYMPANIC MEMBRANE HEALING | 2014 |
|
RU2676483C2 |
| APOPTOSIS MODULATING COMPOSITIONS WITH CONTROLLED RELEASE AND METHODS OF TREATING EAR DISEASES | 2009 |
|
RU2493828C2 |
| METHOD FOR TREATING MIDDLE EAR INFECTION CASES | 2002 |
|
RU2295346C2 |
| INTRANASAL DEXMEDETOMIDINE COMPOSITIONS AND METHODS OF USE THEREOF | 2012 |
|
RU2692245C2 |
| FINAFLOXACIN-INCLUDING COMPOSITIONS, AND METHODS OF TREATING OPHTHALMOLOGICAL, AURAL AND NASAL INFECTIONS | 2010 |
|
RU2570731C2 |
| DIBENZO-AZEPINE COMPOUNDS AND USE THEREOF FOR TREATING EAR DISEASES AND DISORDERS | 2016 |
|
RU2707284C1 |
| METHOD AND PHARMACEUTICAL COMPOSITION FOR ANTIPHLOGISTIC AGENT DELIVERY | 2004 |
|
RU2325189C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HELICOBACTER PYLORI | 2014 |
|
RU2671400C2 |
| METHOD OF BLOOD PRESSURE REDUCTION IN PRE-HYPERTENSIVE INDIVIDUALS AND/OR IN INDIVIDUALS HAVING METABOLIC SYNDROME | 2006 |
|
RU2427382C2 |
| COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | 2008 |
|
RU2484823C2 |
